Biologics, encompassing a wide range of therapeutic products derived from biological sources, have become integral to modern medicine. However, their complex nature poses significant challenges in terms of stability and bioavailability. This article explores various formulation strategies employed to address these challenges, highlighting recent advancements and their implications for the pharmaceutical industry.
HTML PDFShare this article
Journal of Formulation Science & Bioavailability received 23 citations as per Google Scholar report
